Gilead Sciences (GB:0QYQ)
LSE:0QYQ
Holding GB:0QYQ?
Track your performance easily

Gilead Sciences (0QYQ) Financial Statements

1 Followers

Gilead Sciences Financial Overview

Gilead Sciences's market cap is currently ―. The company's EPS TTM is $0.818; its P/E ratio is 97.10; and it has a dividend yield of 3.83%. Gilead Sciences is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $1.57. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 6.95B$ 6.69B$ 7.11B$ 7.05B$ 6.56B
Gross Profit$ 5.41B$ 5.13B$ 5.02B$ 5.49B$ 5.16B
EBIT$ 2.05B$ -4.23B$ 1.91B$ 2.55B$ 1.82B
EBITDA$ 2.75B$ -3.54B$ 2.59B$ 3.23B$ 2.50B
Net Income Common Stockholders$ 1.61B$ -4.17B$ 1.43B$ 2.18B$ 1.04B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 0.00$ 0.00$ 1.18B$ 1.16B$ 6.67B
Total Assets$ 53.58B$ 56.29B$ 62.13B$ 62.37B$ 62.34B
Total Debt$ 23.35B$ 25.19B$ 24.99B$ 24.98B$ 25.25B
Net Debt$ 23.35B$ 25.19B$ 23.81B$ 23.82B$ 18.58B
Total Liabilities$ 35.38B$ 38.84B$ 39.38B$ 40.13B$ 41.24B
Stockholders Equity$ 18.28B$ 17.54B$ 22.83B$ 22.31B$ 21.16B
Cash Flow-
Free Cash Flow$ 1.20B$ 2.11B$ 1.95B$ 2.35B$ 1.48B
Operating Cash Flow$ 1.32B$ 2.22B$ 2.17B$ 2.47B$ 1.62B
Investing Cash Flow$ -307.00M$ -2.21B$ -727.00M$ -229.00M$ -483.00M
Financing Cash Flow$ -2.95B$ -1.36B$ -1.10B$ -2.24B$ -383.00M
Currency in USD

Gilead Sciences Earnings and Revenue History

Gilead Sciences Debt to Assets

Gilead Sciences Cash Flow

Gilead Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis